NEW YORK — Higher costs associated with its Sally Hansen products put a wrinkle in Del Laboratories’ third-quarter financial results.

For the three months ended Sept. 30, the Uniondale, N.Y.-based cosmetics maker said profits slid by 8.7 percent to $4.7 million, or 48 cents a diluted share, compared with $5.1 million, or 54 cents, in the same period last year. The company said the quarterly results were adversely impacted by higher advertising and display costs in support of its new Sally Hansen Healing Beauty product line of skin care makeup and its core Sally Hansen franchise.

To Read the Full Article
SUBSCRIBE NOW

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus